Genomenon and Rady Children's Institute for Genomic Medicine Collaborate to Accelerate Diagnosis of Rare Genetic Disorders in Newborns

ANN ARBOR, Mich., Oct. 7, 2020 /PRNewswire-PRWeb/

The Rady Children's Institute for Genomic Medicine (RCIGM) and Genomenon, Inc. today announced a strategic collaboration to accelerate the diagnosis of critically-ill newborns with rare genetic disorders. The collaboration combines the Institute's genomic research expertise with Genomenon's Mastermind Genomic Search Engine to advance precision medicine for infants in an intensive care setting.